Rosalind Imogen

Global strategic innovation architect, cross-border business ecosystem designer, multi-capital game rule reshaper, enterprise transformation accelerator, investment/venture capital direction

📍 United States🔄 Updated September 2026💼 2 investments📅 7 years investing🗓 Last invested Aug 2020
VC🌍 United States
2
Total investments
1
Early stage
0
Mid stage
0
Late stage
7y
Years active

Portfolio

1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
Apr 2019
Round21 is a sports lifestyle brand founded in 2021 by a former pro athlete, that puts the ART in SPORT to honor the unique identities of sports fans everywhere. What began as a passion project has evolved into a multi-sport platform that creates products and experiences for fans beyond the game.
Experience · 4 entries
All (4)
Investments (2)
2020
Venture Manager
Dec 2020
We aspire to be the world’s most exceptional financial institution, united by our shared values of partnership, client service, integrity, and excellence. Operating at the center of capital markets, we act as one firm, mobilizing our people, capital, and ideas to deliver superior results across our clients’ most complex challenges. For 157 years, Goldman Sachs has delivered world-class execution on a global scale across our leading Global Banking & Markets and Asset & Wealth Management businesses. Apprenticeship is central to our culture, with hands-on coaching and access to leaders who bring decades of experience and expertise. With office locations around the world, we offer a broad range of career opportunities to those who insist on excellence and thrive on performance. Find our Social Media Disclosures here: gs.com/social-media-disclosures
Investor
Aug 2020
Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells. Its primary objective is to unlock the potential of its proprietary technology platforms and intellectual property, enabling to be at the forefront of developing next-generation CAR T-cell therapies. By fully leveraging its innovative technology platforms, Celyad Oncology aims to maximize the transformative impact of its candidate CAR T-cell therapies and redefine the future of CAR T-cell treatments. Celyad Oncology is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.
2019
Investor
Apr 2019
Round21 is a sports lifestyle brand founded in 2021 by a former pro athlete, that puts the ART in SPORT to honor the unique identities of sports fans everywhere. What began as a passion project has evolved into a multi-sport platform that creates products and experiences for fans beyond the game.
2017
Financial Analyst
Dec 2017
Accel is a global venture capital firm that is the first partner to exceptional teams everywhere, from inception through all phases of private company growth. Atlassian, Bumble, CrowdStrike, Fiverr, Flipkart, Freshworks, Qualtrics, Scale, Segment, Slack, Spotify, Squarespace, Tenable, and UiPath are among the companies Accel has backed over the past 40+ years. We help ambitious entrepreneurs build iconic global businesses. For more, visit www.accel.com or www.twitter.com/accel.